Literature DB >> 9032019

Ameloblastin expression in rat incisors and human tooth germs.

S K Lee1, P H Krebsbach, Y Matsuki, A Nanci, K M Yamada, Y Yamada.   

Abstract

We recently identified ameloblastin as an ameloblast-specific gene product from a rat incisor cDNA library (Krebsbach et al., J. Biol. Chem. 271: 4431-4435, 1996). Here we report the developmental pattern of expression of ameloblastin in rat incisors and human tooth germs as visualized by in situ hybridization and immunochemistry. Compared to the expression of amelogenin, the major ameloblast product, ameloblastin mRNA was more widely expressed in ameloblasts from the presecretory to the late maturation stage of development. Ameloblastin mRNA was first observed in the juxtanuclear cytoplasm or presecretory stage ameloblasts, gradually increased in the distal cytoplasm of secretory stage ameloblasts and was found throughout the cytoplasm of early to late maturation stage ameloblasts. The immunostaining of ameloblastin, using a monospecific antibody raised against a recombinant protein, showed intense reactivity in Tomes' processes of secretory stage ameloblasts and surrounding enamel. The immunoreaction was concentrated in the juxtanuclear cytoplasm of late maturation stage ameloblasts. High-resolution colloidal gold immunocytochemistry established the presence of ameloblastin antigenicity in the Golgi apparatus, secretory granules in Tomes' process and enamel. Human tooth germs in early to late bell stage also expressed ameloblastin mRNA and ameloblastin antigenicity in the ameloblasts. Western blot analysis of protein extracts from rat incisor tissues indicated that ameloblastin can be found in the enamel epithelial tissue and in mineralized enamel, as well as in the EDTA decalcification solution. These data indicate that ameloblastin is an ameloblast secretory product which is sequentially expressed from the presecretory to the late maturation stage in rat and human teeth. This unique developmental pattern suggests that ameloblastin may have a broader role in amelogenesis than amelogenin and tuftelin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9032019

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  19 in total

1.  Peptide coatings enhance keratinocyte attachment towards improving the peri-implant mucosal seal.

Authors:  Vasiliki P Koidou; Prokopios P Argyris; Erik P Skoe; Juliana Mota Siqueira; Xi Chen; Lei Zhang; James E Hinrichs; Massimo Costalonga; Conrado Aparicio
Journal:  Biomater Sci       Date:  2018-06-25       Impact factor: 6.843

Review 2.  Cell culture systems for studies of bone and tooth mineralization.

Authors:  Adele L Boskey; Rani Roy
Journal:  Chem Rev       Date:  2008-09-19       Impact factor: 60.622

3.  Adipose tissue-derived stem cell in vitro differentiation in a three-dimensional dental bud structure.

Authors:  Federico Ferro; Renza Spelat; Giuseppe Falini; Annarita Gallelli; Federica D'Aurizio; Elisa Puppato; Maura Pandolfi; Antonio Paolo Beltrami; Daniela Cesselli; Carlo Alberto Beltrami; Francesco Saverio Ambesi-Impiombato; Francesco Curcio
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

4.  Ameloblastin upstream region contains structural elements regulating transcriptional activity in a stromal cell line derived from bone marrow.

Authors:  Margareth V Tamburstuen; Malcolm L Snead; Janne E Reseland; Michael L Paine; Staale P Lyngstadaas
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

5.  Transcription factor Sp3 is essential for post-natal survival and late tooth development.

Authors:  P Bouwman; H Göllner; H P Elsässer; G Eckhoff; A Karis; F Grosveld; S Philipsen; G Suske
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

6.  Transgenic rescue of enamel phenotype in Ambn null mice.

Authors:  Y-H P Chun; Y Lu; Y Hu; P H Krebsbach; Y Yamada; J C-C Hu; J P Simmer
Journal:  J Dent Res       Date:  2010-10-12       Impact factor: 6.116

7.  Ameloblastin modulates osteoclastogenesis through the integrin/ERK pathway.

Authors:  Xuanyu Lu; Yoshihiro Ito; Phimon Atsawasuwan; Smit Dangaria; Xiulin Yan; Tuojiang Wu; Carla A Evans; Xianghong Luan
Journal:  Bone       Date:  2013-02-04       Impact factor: 4.398

8.  Amelogenins as potential buffers during secretory-stage amelogenesis.

Authors:  J Guo; D M Lyaruu; Y Takano; C W Gibson; P K DenBesten; A L J J Bronckers
Journal:  J Dent Res       Date:  2014-12-22       Impact factor: 6.116

9.  Current concepts and occurrence of epithelial odontogenic tumors: I. Ameloblastoma and adenomatoid odontogenic tumor.

Authors:  Suk Keun Lee; Yeon Sook Kim
Journal:  Korean J Pathol       Date:  2013-06-25

10.  Ameloblastin inhibits cranial suture closure by modulating MSX2 expression and proliferation.

Authors:  Phimon Atsawasuwan; Xuanyu Lu; Yoshihiro Ito; Youbin Zhang; Carla A Evans; Xianghong Luan
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.